SciELO - Scientific Electronic Library Online

 
vol.55 issue3Morphine myths and realities: Experience in two Paraguayan centersThe perception of educational assistants and medicine students of the clinical cycle of the FCM-UNA medicine career, on the teaching and learning process of the clinical method author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Anales de la Facultad de Ciencias Médicas (Asunción)

Print version ISSN 1816-8949

Abstract

GARCETE MANOTTI, Lidia et al. Enzyme replacement treatment in exocrine pancreatic insufficiency associated with cystic fibrosis. Cystic fibrosis Working group of the Latin American Society of Pediatric Gastroenterology, Hepatology and Nutrition (LASPHGAN). An. Fac. Cienc. Méd. (Asunción) [online]. 2022, vol.55, n.3, pp.76-85. ISSN 1816-8949.  https://doi.org/10.18004/anales/2022.055.03.76.

Cystic fibrosis (CF) is an inherited disorder of the exocrine secretion glands, considered the most frequent cause of exocrine pancreatic insufficiency (EPI) in childhood. This review summarizes the landscape of enzyme replacement therapy in PEI associated with CF, the available formulations, their dosage and mode of administration, as well as the current limitations and challenges and potential areas for future development.

Keywords : cystic fibrosis; exocrine pancreatic insufficiency; malabsorption; enzyme replacement..

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )